Nigeria study examines parvo breakthrough infections in vaccinated dogs

A new study in Preventive Veterinary Medicine examines why some vaccinated dogs in Nigeria still developed canine parvovirus while presenting to clinics with gastroenteritis. The cross-sectional observational study focuses on “breakthrough” infections, pointing to a mix of likely contributors: mismatch between circulating field strains and vaccine strains, interference from maternally derived antibodies, and gaps in vaccination protocol compliance. That fits with prior Nigerian molecular surveillance showing ongoing viral evolution, including circulation of CPV-2a and CPV-2c variants, and earlier concerns that locally used vaccines may not fully reflect the strains circulating in the field. (pubmed.ncbi.nlm.nih.gov)

Why it matters: For veterinary professionals, the study is a reminder that a vaccination history alone doesn’t rule out parvo in a vomiting or diarrheic dog, especially in high-prevalence settings. Current AAHA and WSAVA guidance already emphasizes that maternal antibodies can block effective immunization in young puppies, creating a “window of susceptibility” that supports repeated puppy vaccinations through at least 16 weeks of age, with careful attention to storage, handling, timing, and completion of the series. In markets where CPV variants are shifting, the paper also adds weight to calls for ongoing strain surveillance and closer scrutiny of real-world vaccine performance. (wsava.org)

What to watch: Watch for the full paper’s data on which risk factors were strongest, and whether it prompts more discussion around vaccine matching, protocol updates, or serologic testing in high-risk puppies. (wsava.org)